A pharmacist from UMass Medical School’s Clinical Pharmacy Services discusses the efficacy and expected costs of specialty drugs in the pipeline for nonalcoholic steatohepatitis, atopic dermatitis, rheumatoid arthritis, multiple sclerosis and ovarian cancer in Specialty Pharmacy Continuum.
The US Business Leadership Network (USBLN) has chosen UMass Medical School’s Work Without Limits (WWL) to become its Massachusetts affiliate, a designation that will expand efforts to promote and support disability inclusion among employers in the state.
UMass Medical School’s Clinical Pharmacy Services has partnered with InterVRx to review the accuracy, completeness and usability of specialty drug clinical protocols used within its patient monitoring platform.
The Executive Office of Elder Affairs (EOEA) and Jewish Family and Children’s Service (JF&CS) are collaborating with Mass Council on Aging (MCOA), the Alzheimer’s Association, UMass Medical School and other partners on the Dementia Friendly Massachusetts Initiative, which strives to make communities supportive and inclusive of individuals living with dementia and their families.
The successful recruitment strategies of the Southern New England Practice Transformation Network (SNE-PTN), a collaborative led by UMass Medical School and UConn Health, were selected by the Centers for Medicare and Medicaid Services (CMS) to present in a poster at the 2016 CMS Quality Conference at the Baltimore Marriott Waterfront Hotel in Maryland Dec. 13-16.
UMass Medical School Health policy attorneys will present on 1115 and 1332 waivers at the American Association of Health and Human Services Attorneys (AAHHSA) annual national conference in Norfolk, Virginia.
UMass Medical School Medicaid experts will discuss how we help states navigate high-priority challenges, contain Medicaid costs and improve outcomes at the National Association of Medicaid Directors (NAMD) Fall Conference, November 6-8, Arlington, VA. Our tream will be at booth 74.
The Academic Consortium on Criminal Justice Health (ACCJH) will increase the number of scholarships, structured mentorships, and networking opportunities available to students, junior investigators and stakeholders with funding from The Jacob and Valeria Langeloth Foundation. ACCJH is supported by UMass Medical School.
Gillette Stadium ticket taker William Fahey and his employer, The Kraft Group’s TeamOps, have been recognized by UMass Medical School’s Work Without Limits with the exemplary employee and employer awards for advancing workplace diversity.
The number of employers who are actively recruiting and accommodating employees with disabilities has increased over the past decade, a UMass Medical School disability employment advocate told the Boston Herald.
A clinical pharmacist from UMass Medical School’s Clinical Pharmacy Services division will present on high-impact specialty pipeline drugs expected to reach the market, with a focus on their budget impact, at the Eastern Medicaid Pharmacy Administrators Association’s 40th annual meeting Nov. 14 at Wentworth by the Sea in New Castle, N.H.
Boston Marathon bombing survivor Heather Abbott will deliver a keynote address, Overcoming Adversity, at Raise the Bar Hire! October 25 in Norwood. The annual conference is hosted by UMass Medical School’s Work Without Limits, a statewide network of engaged employers and innovative, collaborative partners that aims to increase employment among individuals with disabilities.
Leaders of UMass Medical School’s Disability and Community Services division will discuss how to design complex care management and better coordinate care at the World Congress “Managing Long Term Support Services for Complex Populations” conference Oct. 24-25 at Westin Tyson's Corner in Falls Church, Virginia.
Two programs and one employee of UMass Medical School’s Commonwealth Medicine division are among those being honored by the 2016 Commonwealth of Massachusetts Performance Recognition Program.
Many seniors are prescribed medications considered high-risk because of their potential to cause adverse reactions and events. The U.S. Food and Drug Administration (FDA) is addressing this issue with its recent release of safety tips for older adults. Health insurers can do even more by implementing a high-risk medication intervention program.